Evidence map›Paper›PMID 11709511›Full record

ArticleGut2001

Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease.

E Louis, A Collard, A F Oger, E Degroote, F A Aboul Nasr El Yafi, J Belaiche

3 registry-linked trialsAbstract read
In one paragraph

Article in Gut, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 309 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
309citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01442025 phase4completednot on this mapstarted 2012, after this paper: background citation

A Randomized Controlled Trial Investigating Tailored Treatment With Infliximab for Active Luminal Crohn's Disease

TypeinterventionalSponsorGroupe d'Etude Therapeutique des Affections Inflammatoires DigestivesRan2012 to 2015Enrolled121ConditionsCrohn's DiseaseArmsInfliximab
NCT03291743 naterminatednot on this mapstarted 2017, after this paper: background citation

The Biologic Onset of Crohn's Disease: A Screening Study in First Degree Relatives

TypeinterventionalSponsorCarilion ClinicRan2017 to 2022Enrolled38ConditionsCrohn Disease, Genetic Predisposition, IBDArmsCapsule endoscopy
NCT06457035 completednot on this mapstarted 2005, after this paper: background citation

Development and Validation of a Nomogram for Predicting Surgery in Newly-diagnosed Crohn's Disease: a Retrospective Cohort Study

TypeobservationalSponsorFirst Affiliated Hospital, Sun Yat-Sen UniversityRan2005 to 2023Enrolled490ConditionsNewly-diagnosed Crohn's DiseaseArmsimmunosuppressant
3 · Its place in the literature

Who cites it

309 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Azathioprine is more effective than mesalazine at preventing recurrent bowel obstruction in patients with ileocecal Crohn's disease.Medical science monitor : international medical journal of experimental and clinical research · 2014
    Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. [Diagnostic imaging of the small bowel].Radiologie (Heidelberg, Germany) · 2026
    Review

249 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

E LouisDepartment of Gastroenterology, University Hospital of Liège, Belgium. edouard.louis@ulg.ac.be
A Collard
A F Oger
E Degroote
F A Aboul Nasr El Yafi
J Belaiche

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCrohn's disease is a heterogeneous disorder with both a genetic and environmental aetiology. Clinical classifications of the disease, such as the newly proposed Vienna classification, may help to define subgroups of patients suitable for studying the influence of specific genetic or environmental factors.

aimTo assess the stability over the course of the disease of its location and behaviour, as determined according to the Vienna classification. PATIENTS AND

methodsThe notes of 297 Crohn's disease patients regularly followed up at our institution were carefully reviewed retrospectively. The behaviour and location of the disease according to the Vienna classification were determined at diagnosis and after 1, 3, 5, 10, 15, 20, and 25 years of follow up. The proportions of the different behaviours and locations of the disease were calculated at these time points. A statistical analysis of the evolution of these characteristics over 10 years was performed on a subgroup of 125 patients with at least 10 years of follow up. The influence of age at diagnosis on location and behaviour of the disease was assessed as well as the influence of location on the behaviour of the disease.

resultsThe location of the disease remained relatively stable over the course of the disease. Although the proportion of patients who had a change in disease location became statistically significant after five years (p=0.01), over 10 years only 15.9% of patients had a change in location (p<0.001). We observed a more rapid and prominent change in disease behaviour, which was already statistically significant after one year (p=0.04). Over 10 years, 45.9% of patients had a change in disease behaviour (p<0.0001). The most prominent change was from non-stricturing non-penetrating disease to either stricturing (27.1%; p<0.0001) or penetrating (29.4%; p<0.0001) disease. Age at diagnosis had no influence on either location or behaviour of disease. Ileal Crohn's disease was more often stricturing, and colonic or ileocolonic Crohn's disease was more often penetrating: this was already the case at diagnosis and became more prominent after 10 years (p<0.05).

conclusionsLocation of Crohn's disease, as defined by the Vienna classification, is a relatively stable phenotype which seems suitable for phenotype-genotype analyses. Behaviour of Crohn's disease according to the Vienna classification varies dramatically over the course of the disease and cannot be used in phenotype-genotype analyses. The potential influence of genes on the behaviour of Crohn's disease should be studied in subgroups of patients defined by their disease behaviour after a fixed duration of disease.

Indexed as

AdultAgedAge of OnsetColonConstriction, PathologicCrohn DiseaseDisease ProgressionFollow-Up StudiesHumansIleumMiddle AgedPhenotypeRetrospective StudiesTime Factors

Identifiers

PMID11709511
PMCPMC1728556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.